PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions

Renal Disease, End Stage

Interventions

DRUG

Amisulpride IV

A single 10mg IV dose of Amisulpride given over 1 minute

DRUG

Amisulpride Oral Tablet

A single 10mg dose given as an oral tablet

Trial Locations (1)

Panax Clinical Research, Miami Lakes